Holen Sie sich die Stockscreener-App
1.30
2.99%
-0.04
Handel nachbörslich:
1.34
0.04
+3.08%
Schlusskurs vom Vortag:
$1.34
Offen:
$1.33
24-Stunden-Volumen:
216.54K
Relative Volume:
0.67
Marktkapitalisierung:
$40.89M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-69.00M
KGV:
-0.4676
EPS:
-2.78
Netto-Cashflow:
$-55.26M
1W Leistung:
-2.26%
1M Leistung:
-2.26%
6M Leistung:
-75.75%
1J Leistung:
-84.15%
1-Tages-Spanne:
$1.30
$1.3499
1-Wochen-Bereich:
$1.30
$1.40
52-Wochen-Spanne:
$1.05
$10.00
Acrivon Therapeutics Inc Stock (ACRV) Company Profile
Firmenname
Acrivon Therapeutics Inc
Sektor
Branche
Telefon
617-207-8979
Adresse
480 ARSENAL WAY, SUITE 100, WATERTOWN
Vergleichen Sie ACRV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACRV
Acrivon Therapeutics Inc
|
1.30 | 42.15M | 0 | -69.00M | -55.26M | -2.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Acrivon Therapeutics Inc Stock (ACRV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-05 | Fortgesetzt | Piper Sandler | Overweight |
| 2025-01-31 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-09-16 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2024-04-29 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2024-03-01 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-12-15 | Fortgesetzt | Jefferies | Buy |
| 2023-10-05 | Eingeleitet | Maxim Group | Buy |
| 2023-06-02 | Eingeleitet | Oppenheimer | Outperform |
| 2023-05-08 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-04-27 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2023-04-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-12-12 | Eingeleitet | Cowen | Outperform |
| 2022-12-12 | Eingeleitet | Jefferies | Buy |
| 2022-12-12 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Acrivon Therapeutics Inc Aktie (ACRV) Neueste Nachrichten
Will Acrivon Therapeutics Inc. continue its uptrendJuly 2025 Summary & Daily Price Action Insights - Newser
Forecasting Acrivon Therapeutics Inc. price range with options dataJuly 2025 Chart Watch & Advanced Technical Analysis Signals - Newser
Market reaction to Acrivon Therapeutics Inc.’s recent newsCEO Change & Daily Market Momentum Tracking - Newser
Long term hold vs stop loss in Acrivon Therapeutics Inc.July 2025 Sentiment & Detailed Earnings Play Strategies - Newser
Detecting support and resistance levels for Acrivon Therapeutics Inc.Weekly Profit Report & High Return Trade Guides - Newser
Understanding Acrivon Therapeutics Inc.’s price movement2025 Volatility Report & Intraday High Probability Alerts - Newser
What dividend growth rate does Acrivon Therapeutics Inc. offer2025 Key Lessons & Detailed Earnings Play Strategies - khodrobank.com
Is Acrivon Therapeutics Inc. trending in predictive chart modelsJuly 2025 Reactions & Technical Entry and Exit Alerts - Newser
Has Acrivon Therapeutics Inc. found a price floorSwing Trade & Safe Entry Point Alerts - Newser
Relative strength of Acrivon Therapeutics Inc. in sector analysisJuly 2025 Intraday Action & Fast Gain Stock Tips - Newser
Should you hold or exit Acrivon Therapeutics Inc. now2025 Big Picture & Technical Buy Zone Confirmations - Newser
Has Acrivon Therapeutics Inc. formed a bullish divergenceJuly 2025 Analyst Calls & Precise Buy Zone Tips - Newser
Acrivon Therapeutics Inc. stock trend outlook and recovery pathEarnings Overview Summary & Daily Profit Maximizing Tips - Newser
Is Acrivon Therapeutics Inc. stock suitable for long term investing2025 Short Interest & Entry and Exit Point Strategies - khodrobank.com
Is Acrivon Therapeutics Inc. stock entering bullish territory2025 Growth vs Value & Weekly Chart Analysis and Trade Guides - Newser
Real time breakdown of Acrivon Therapeutics Inc. stock performanceMarket Trend Report & Capital Protection Trade Alerts - Newser
Full technical analysis of Acrivon Therapeutics Inc. stockJuly 2025 Decliners & High Conviction Buy Zone Picks - Newser
Multi factor analysis applied to Acrivon Therapeutics Inc.2025 Price Targets & Precise Trade Entry Recommendations - Newser
What are analysts’ price targets for Acrivon Therapeutics Inc.July 2025 WrapUp & Smart Allocation Stock Reports - khodrobank.com
Tick level data insight on Acrivon Therapeutics Inc. volatilityJuly 2025 Momentum & Entry and Exit Point Strategies - Newser
Building trade automation scripts for Acrivon Therapeutics Inc.Weekly Trade Analysis & Safe Entry Point Identification - Newser
Will Acrivon Therapeutics Inc. outperform during market ralliesShort Setup & Reliable Intraday Trade Alerts - khodrobank.com
Acrivon Therapeutics Inc. stock prediction for this week2025 Price Momentum & High Accuracy Swing Trade Signals - Newser
Does Acrivon Therapeutics Inc. have declining or rising EPS2025 Short Interest & Step-by-Step Swing Trade Plans - khodrobank.com
Is Acrivon Therapeutics Inc. stock bottoming outPortfolio Return Report & Real-Time Stock Movement Alerts - Newser
How to read the order book for Acrivon Therapeutics Inc.2025 Big Picture & Technical Confirmation Alerts - Newser
What are Acrivon Therapeutics Inc.’s growth leversPortfolio Profit Report & Precise Entry and Exit Recommendations - khodrobank.com
Is Acrivon Therapeutics Inc. a turnaround storyInflation Watch & Proven Capital Preservation Tips - خودرو بانک
Can Acrivon Therapeutics Inc. maintain sales growthQuarterly Profit Report & Community Consensus Picks - khodrobank.com
Will Acrivon Therapeutics Inc. announce a stock split2025 Price Action Summary & Short-Term High Return Ideas - khodrobank.com
Exit strategy if you’re trapped in Acrivon Therapeutics Inc.2025 Buyback Activity & Stepwise Entry and Exit Trade Signals - Newser
Aug Fed Impact: What dividend growth rate does Acrivon Therapeutics Inc. offerJuly 2025 Update & Consistent Profit Trade Alerts - خودرو بانک
Why Acrivon Therapeutics Inc. is moving today2025 Momentum Check & Low Drawdown Trading Strategies - Newser
Is Acrivon Therapeutics Inc. forming a double bottomSwing Trade & Intraday High Probability Alerts - khodrobank.com
Visual analytics tools that track Acrivon Therapeutics Inc. performance2025 Technical Patterns & High Yield Stock Recommendations - Newser
Why Acrivon Therapeutics Inc. stock attracts strong analyst attentionMarket Performance Report & Growth Focused Investment Plans - Newser
Should you wait for a breakout in Acrivon Therapeutics Inc.Long Setup & Weekly Setup with ROI Potential - Newser
How institutional ownership impacts Acrivon Therapeutics Inc. stockWeekly Gains Summary & Growth Focused Stock Reports - Newser
Using fundamentals and technicals on Acrivon Therapeutics Inc.2025 Top Decliners & Safe Swing Trade Setups - Newser
What’s the recovery path for long term holders of Acrivon Therapeutics Inc.Weekly Gains Report & Accurate Intraday Trade Tips - Newser
Finanzdaten der Acrivon Therapeutics Inc-Aktie (ACRV)
Umsatz
Nettogewinn
Free Cashflow
ENV
Acrivon Therapeutics Inc-Aktie (ACRV) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 10% Owner |
May 01 '25 |
Sale |
1.34 |
298,886 |
400,507 |
3,104,139 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Apr 25 '25 |
Sale |
1.95 |
1,054,669 |
2,056,605 |
4,306,189 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Apr 29 '25 |
Sale |
1.41 |
250,000 |
352,500 |
3,840,906 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Apr 28 '25 |
Sale |
1.56 |
215,283 |
335,841 |
4,090,906 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):